Oramed Pharmaceuticals
ORMP
#9090
Rank
โ‚ฌ0.10 B
Marketcap
2,58ย โ‚ฌ
Share price
4.66%
Change (1 day)
10.38%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚ฌ6.89 Million

According to Oramed Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ6.89 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oramed Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ9.54 M-81.7%
2023-12-31โ‚ฌ52.15 M433.55%
2022-12-31โ‚ฌ9.77 M
2021-08-31โ‚ฌ9.72 M-1.25%
2020-08-31โ‚ฌ9.84 M-29.01%
2019-08-31โ‚ฌ13.86 M-1.32%
2018-08-31โ‚ฌ14.05 M-14.04%
2017-08-31โ‚ฌ16.35 M9.66%
2016-08-31โ‚ฌ14.9 M996.8%
2015-08-31โ‚ฌ1.35 M76.86%
2014-08-31โ‚ฌ0.76 M91.95%
2013-08-31โ‚ฌ0.4 M-67.01%
2012-08-31โ‚ฌ1.21 M189.78%
2011-08-31โ‚ฌ0.41 M-14.38%
2010-08-31โ‚ฌ0.48 M34.82%
2009-08-31โ‚ฌ0.36 M-42.14%
2008-08-31โ‚ฌ0.62 M-39.87%
2007-08-31โ‚ฌ1.04 M119.84%
2006-08-31โ‚ฌ0.47 M1186.14%
2005-08-31โ‚ฌ0.03 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚ฌ0.99 B 14,395.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚ฌ45.84 B 664,499.43%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚ฌ56.22 B 814,948.76%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
โ‚ฌ45.99 M 566.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
โ‚ฌ73.03 M 958.73%๐Ÿ‡บ๐Ÿ‡ธ USA